| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/28/2013 | CN103270031A Substituted sodium-1H-pyrazole-5-olate |
| 08/28/2013 | CN103270024A Novel substituted isoquinoline derivative |
| 08/28/2013 | CN103265623A Polypeptide having protection effect on cerebral ischemic injuries, and its application |
| 08/28/2013 | CN103265517A 3-substituted coumarin derivative and use thereof |
| 08/28/2013 | CN103265515A Sibiraea angustata acid a, stereoisomer and applications thereof |
| 08/28/2013 | CN103265480A Quinolinedione derivative, and preparation method and use thereof |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN103263668A Rifaximin anti-rectal dysfunction preparation |
| 08/28/2013 | CN103263660A Earthworm protein for reducing blood sugar and blood pressure and eliminating diabetic complications and application pf earthworm protein |
| 08/28/2013 | CN103263638A Application of medicine to medicine capable of increasing collateral circulation |
| 08/28/2013 | CN103263637A Medicine for treating myocardial infarction and preparation method thereof |
| 08/28/2013 | CN103263606A Traditional Chinese medicine composition for treating diabetic foot by foot bath nursing and application of traditional Chinese medicine composition |
| 08/28/2013 | CN103263594A Traditional Chinese medicine composition for treating dilated cardiomyopathy |
| 08/28/2013 | CN103263585A Chinese medicine composition for treating haemorrhoids hematochezia |
| 08/28/2013 | CN103263574A Traditional Chinese medicine formula for treating hypertrophic cardiomyopathy |
| 08/28/2013 | CN103263566A Traditional Chinese medicine composition for treating bone dilated cardiomyopathy |
| 08/28/2013 | CN103263549A Chinese medicine fumigating and washing agent for treating diabetic feet |
| 08/28/2013 | CN103263548A Embrocation for treating haemorrhoids and application thereof |
| 08/28/2013 | CN103263534A Traditional Chinese medicine composition for treating haemorrhoids and preparation method thereof |
| 08/28/2013 | CN103263502A Medicament for treating cerebrovascular disease sequelae |
| 08/28/2013 | CN103263501A Traditional Chinese medicine compound for treating coronary heart disease |
| 08/28/2013 | CN103263467A Potent medicament of brain-and-heart, preparation method and content determination |
| 08/28/2013 | CN103263454A Traditional Chinese medicine for treating coronary heart disease |
| 08/28/2013 | CN103263453A Traditional Chinese medicine preparation for treatment of hyperlipidemia, hyperglycemia, high blood viscosity and hypertension and preparation method thereof |
| 08/28/2013 | CN103263448A Fermentation bacteria used for fermentation pretreatment to improve extraction of Ginkgo biloba L. leaf flavone and application |
| 08/28/2013 | CN103263439A CD34 stem cell-related methods and compositions |
| 08/28/2013 | CN103263432A Traditional Chinese medicine monomer compound preparation for preventing and treating diabetic heart injuries and preparation method thereof |
| 08/28/2013 | CN103263424A Application of Myriberine A in preparation of medicine for treating myocardial ischemia |
| 08/28/2013 | CN103263422A Application of myriberine A in preparation of medicaments for treating ischemic brain injury |
| 08/28/2013 | CN103263421A Application of myriberine A in preparation of medicaments for treating or preventing chronic heart failure |
| 08/28/2013 | CN103263419A New application of pharmaceutical composition of metformin and 5-methyltetrahydrofolate |
| 08/28/2013 | CN103263411A Ginkgolide composition and application thereof |
| 08/28/2013 | CN103263408A Allicin nano liposome and preparation method and application thereof |
| 08/28/2013 | CN103263402A Water-drinking-free oral drug composition and preparation method thereof |
| 08/28/2013 | CN103263395A Telmisartan tablet preparation and preparation method thereof |
| 08/28/2013 | CN103263384A Edaravone composition injection and preparation method thereof |
| 08/28/2013 | CN102846595B Application of flavonoid compound WX-03 in relaxation of vascular smooth muscles |
| 08/28/2013 | CN102697846B Yufengningxin coated dripping pill and preparation method thereof |
| 08/28/2013 | CN102657839B Traditional Chinese medicine capsule for treating coronary heart disease |
| 08/28/2013 | CN102580117B Application of miRNA-122 restraining agent to preparation of medicament for treating congenital heart disease |
| 08/28/2013 | CN102580027B Traditional Chinese medicine bag for treating vertebral artery cervical spondylosis and nursing method using same |
| 08/28/2013 | CN102579804B Chinese medicine for treating stenocardia |
| 08/28/2013 | CN102579502B Toxic-free method for separating shuck of eupolyphaga egg from internal egg |
| 08/28/2013 | CN102579442B Compound preparation containing benidipine hydrochloride and atorvastatin calcium and application for compound preparation |
| 08/28/2013 | CN102526628B Medicinal composition for treating myocardial infarction |
| 08/28/2013 | CN102526612B Traditional Chinese medicine composite for curing angina pectoris |
| 08/28/2013 | CN102526279B Chinese medicinal composition for treating central high fever caused by acute cerebrovascular disease and preparation method for Chinese medicinal composition |
| 08/28/2013 | CN102430090B Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof |
| 08/28/2013 | CN102389533B Medicinal composition for treating cerebral apoplexy and preparation method thereof |
| 08/28/2013 | CN102389430B Application of small molecular compounds to preparation of anti-lung-cancer medicine |
| 08/28/2013 | CN102349889B Composition containing dronedarone |
| 08/28/2013 | CN102302529B Purple ginseng prepared by vaccinium fermentation method and application thereof in medicine |
| 08/28/2013 | CN102293976B Lingxiang herbal pillow |
| 08/28/2013 | CN102260266B Pyrazolo[3,4-d]pyrimidone compounds and application thereof in preparation of phosphodiesterase IX inhibitor |
| 08/28/2013 | CN102250914B Protein for treating ocular vascular proliferation |
| 08/28/2013 | CN102093320B Soluble epoxide hydrolase inhibitor |
| 08/28/2013 | CN102078385B External fig ointment |
| 08/28/2013 | CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/28/2013 | CN101787016B Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 08/28/2013 | CN101475619B Preparation and use of Linaria vulgaris flavone and total flavone thereof |
| 08/28/2013 | CN101134058B Health products having blood fat and blood pressure reducing functions and manufacturing method thereof |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518997 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518956 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518915 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| 08/27/2013 | US8518884 Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor |
| 08/27/2013 | US8518883 Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand |
| 08/27/2013 | US8518451 Thyroid hormone analogs and methods of use |
| 08/27/2013 | US8518416 Compositions and methods for treatment of microbial infections |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/22/2013 | WO2013123165A1 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid [1,3]dioxol-4-ylmethyl ester |
| 08/22/2013 | WO2013123094A2 Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions |
| 08/22/2013 | WO2013122624A1 Azetidinone cholesterol absorption inhibitor (ezetimibe) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| 08/22/2013 | WO2013122623A1 Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (cvd) who are deficient in blood epa and dha levels |
| 08/22/2013 | WO2013122621A1 Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death |
| 08/22/2013 | WO2013122446A1 Composition for preventing tachycardia during heart pain treatment |
| 08/22/2013 | WO2013120935A1 Pharmaceutical compositions for combination therapy |
| 08/22/2013 | WO2013120896A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (pde4) |
| 08/22/2013 | WO2013120771A1 Imidazolylketone derivatives asd aldosterone synthase inhibitors |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217676 5ht2c receptor modulators |
| 08/21/2013 | EP2628733A1 Acylbenzene derivative |
| 08/21/2013 | EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders |
| 08/21/2013 | EP2628488A1 Sustained-release pharmaceutical composition |
| 08/21/2013 | EP2628485A1 New use of chemical ingredients in cynomorium as phytoestrogen |
| 08/21/2013 | EP2627637A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides |
| 08/21/2013 | EP2627343A2 A method for promoting the synthesis of collagen and proteoglycan in chondrocytes |
| 08/21/2013 | EP2627342A2 Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium |
| 08/21/2013 | CN203138934U Magnetic health-care mattress for treating osphyalgia, leg pain and bedsore |
| 08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
| 08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
| 08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
| 08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 08/21/2013 | CN103261185A Continuous arycyclic compound |
| 08/21/2013 | CN103260647A EGFR antagonist for the treatment of heart disease |
| 08/21/2013 | CN103260623A Bepotastine compositions |
| 08/21/2013 | CN103260606A Compositions and methods for cardiac therapy |
| 08/21/2013 | CN103255076A Bacillus spp and hyaluronidase and preparation method and purpose thereof |